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As with most diagnostic technologies, ultrasound imaging
reflects a trade-off between image resolution and energy ab-
sorption in tissue. With diagnostic ultrasound, current upper
limits on beam intensity have not been correlated with dem-
onstrated harmful effects. Microcavitation has been observed
at intensities near these limits, but its biological significance
is unknown. This Point/Counterpoint explores whether upper
intensity limits should be removed to permit improvements
in the quality of ultrasound images.
Arguing for the Proposition is
William D. O’Brien, Jr., Ph.D.
Dr. O’Brien is Professor of
Electrical and Computer Engi-
neering and of Bioengineering,
College of Engineering; Pro-
fessor of Bioengineering, Col-
lege of Medicine; and Director
of the Bioacoustics Research
Laboratory at the University of
Illinois. Previously, he worked
at the Bureau of Radiological
Health ~currently the Center for Devices and Radiological
Health! of the U.S. Food and Drug Administration. He is a
fellow of four professional societies; has served as president
of the IEEE Ultrasonics, Ferroelectrics, and Frequency Con-
trol Society and the American Institute of Ultrasound in
Medicine; and is Editor-in-Chief of the IEEE Transactions
on Ultrasonics, Ferroelectrics, and Frequency Control. His
research interests involve the many areas of ultrasound–
tissue interaction, including spectroscopy, risk assessment,1 Med. Phys. 28 1, January 2001 0094-2405Õ2001Õ2biological effects, tissue characterization, dosimetry, and im-
aging for which he has published 215 papers.
Arguing against the Proposi-
tion is Douglas Miller, Ph.D.
Dr. Miller is a Senior Research
Scientist at the University of
Michigan Department of Radi-
ology. He received a Ph.D. in
Physics from the University of
Vermont in 1976, and worked
at Battelle Pacific Northwest
National Laboratory on bio-
electromagnetics and ultra-
sonic biophysics research be-
fore moving to Michigan. Dr.
Miller has served on ultrasound safety review groups of the
American Institute of Ultrasound in Medicine, World Fed-
eration of Ultrasound in Medicine and the National Council
on Radiation Protection and Measurements. Present NIH
projects include research on the bioeffects associated with
contrast aided diagnostic ultrasound and on ultrasound en-
hanced cancer gene therapy.
FOR THE PROPOSITION: William D. O’Brien, Jr.,
Ph.D.
Opening Statement
Regulatory control of diagnostic ultrasound equipment in
the U.S. can be traced to passage of the 1976 Medical Device
Amendments to the Food, Drug, and Cosmetic Act. When
the FDA initiated the regulation of diagnostic ultrasound
equipment in its 1985 ‘‘510~k! premarket notification,’’
application-specific intensity limits were set that manufactur-181Õ1Õ3Õ$18.00 © 2001 Am. Assoc. Phys. Med.
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to assess if a new device was ‘‘substantially equivalent,’’ in
safety and effectiveness, to diagnostic ultrasound equipment
on the market prior to 1976. However, the intensity limits
were not based on safety or effectiveness but rather on the
maximum intensity limits of diagnostic ultrasound equip-
ment at the time when the Amendments were enacted, in
1976; hence the term pre-amendments levels. To emphasize
the FDA’s date-based regulatory approach, as opposed to
safety and efficacy based, the American Institute of Ultra-
sound in Medicine notified the FDA in mid-1986 that there
existed prior to May 28, 1976 at least two diagnostic ultra-
sound devices with intensity levels greater than the 1985
application-specific intensity limits. In early 1987, the FDA
updated their limits to the higher intensity levels.
Following widespread approval of the voluntary Output
Display Standard ~ODS! in early 1990, the FDA essentially
adopted the ODS for its regulatory guidelines. The ODS did
not include upper limits. Nevertheless, the FDA added
application-nonspecific guideline upper limits that were still
based on the 1976 pre-amendments levels.
Problems with the date-based upper-limit regulatory ap-
proach include ~1! a complicated set of rules and procedures
by which manufacturers verify to the FDA that their equip-
ment is in compliance, and the costs associated with these
requirements; ~2! a perception that these upper limits are
safe; ~3! a demonstrated lack of attention to ODS education
materials about the safety-based biophysical indicators; ~4!
the exposure of patients at these upper limits for which there
may be safety concerns; ~5! a limiting of future clinical ben-
efits by preventing the development of more advanced diag-
nostic ultrasound systems at higher levels; and, finally, ~6! a
recognition that limiting diagnostic ultrasound capabilities
may, in fact, be responsible for greater patient risk due to
either an inadequate diagnosis, or to the use of an additional
diagnostic procedure for which there is a defined risk.
The elimination of the upper-limit regulatory approach
would have the following benefits: ~1! a less complicated set
of rules and procedures by manufacturers, and at less cost;
~2! the elimination of the perception that there are safe lim-
its; ~3! more attention to the ODS education materials; ~4!
more attention to the ODS-based biophysical indicators; ~5!
making available research opportunities to develop advanced
diagnostic procedures; and ~6! providing the diagnostic ca-
pability to obtain an adequate diagnosis if higher levels are
required.
To apply rigid controls to ultrasound intensity without a
proper scientific justification benefits no one, particularly the
patient. The physician is a professional trained to provide
health care by making informed benefit–risk judgements.
The FDA’s regulatory approach had denied the physician the
need to become informed about such benefit–risk issues, and
for that we are all worse off.
Rebuttal
The current government-mandated upper-intensity-limit
regulatory approach has placed the risk side of the risk–Medical Physics, Vol. 28, No. 1, January 2001benefit decision on the FDA, not with physicians trained to
make such decisions. This is not how good medicine should
be practiced. In an ideal world, the government would pro-
tect us. The government consists of individuals like you and
me, and none of us have the knowledge or wisdom to know
how to provide long-distance protection. Protection goes
well beyond making sure that diagnostic devices do not pro-
duce any bioeffects. Protection must include on-the-scene
decision making. In other words, a fundamental clinical issue
is an accurate and safe diagnosis of the patient. That is why
physicians receive extensive training in the risk–benefit de-
cision making process.
My opponent argues that risk can be eliminated by limit-
ing outputs to values below the threshold. Obviously, this
refers to ultrasound-induced risk. What about the risk asso-
ciated with an insufficient diagnostic quality image? What
about the follow-on diagnostic procedure that might have a
significant hazard? We cannot view risk narrowly. It must be
viewed in the broadest sense, that of providing the best di-
agnosis of the patient.
My opponent also argues that limits provide a conceptual
separation between diagnostic and therapeutic uses of ultra-
sound, and that built-in safety limits free the operator from
basic issues such as safety, equipment operation, and com-
plex dose calculations. Arbitrary boundaries between types
of equipment are artificial, but operator training is not. Users
must have appropriate training. The safety issue must be ar-
gued on what is best for the patient’s health.
My opponent finally argues that without limits, manufac-
turers would be prone to engage in competition for higher
power for anticipated marginal increases in image quality.
Even if these were true, and this is unsupported, the marginal
increase in image quality might make the diagnostic differ-
ence for some patients. Is this not worth it? Should we not
try it?
AGAINST THE PROPOSITION: Douglas Miller,
Ph.D.
Opening Statement
The use of upper limits appears to be an ideal way to
promote the safety of diagnostic ultrasound examinations.
Bioeffects of ultrasound occur by way of indirect mecha-
nisms, such as heating or acoustical cavitation, and appear to
have identifiable thresholds. The risk of such an effect can be
eliminated by limiting outputs to values below the threshold.
Of course, the exact forms and values of upper limits on
instrument output should be continually questioned and im-
proved. The present guideline limits1 are arbitrarily linked to
the state of the art in 1976, rather than to scientific principles.
However, through deliberation and consensus within the
ultrasound community, the restrictive limits originally ap-
plied to many examinations have been raised to the benefit of
effective diagnosis. In addition, on-screen readouts of ther-
mal and mechanical exposure indices provided on many re-
cent systems are valuable for the identification and manage-
ment of worse-case conditions, for which some potential for
bioeffects exists with current machines both from heating
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likely on lung or intestine!.
The use of well-chosen upper limit guidelines for diag-
nostic ultrasound also has several other benefits. Limits pro-
vide a conceptual separation of diagnostic and therapeutic
uses of ultrasound, thus delineating regimes for patient safety
on the one hand, and for effective treatment ~e.g., physical
therapy, surgery, or lithotripsy! on the other hand. Simple
built-in safety limits free the operator from complex dose
calculations, detailed risk/benefit determinations or extensive
safety training for use of an instrument. Furthermore, au-
thoritative upper limits engender a degree of public confi-
dence in the safety of examinations not possible without
them.
Eliminating upper limit guidelines is a bad idea for sev-
eral reasons. If this were done, instrument manufacturers
would be prone to engage in competition for higher power
for anticipated marginal increases in image quality ~e.g., a
doubling of intensity only provides an additional 6% imag-
ing depth, even for linear propagation2!. Alternately, higher
output power might be substituted for expensive receiver
amplifiers, thus increasing risk with no real patient benefit.
Most importantly, it seems likely that patient harm would
eventually be encountered.
In summary, guideline upper limits for diagnostic ultra-
sound have many advantages, and even the present imperfect
limits have served manufacturers, physicians and patients
well. Eliminating limits, which would likely be of only mar-
ginal value for improving image quality, would also elimi-
nate the confidence of the medical community and the gen-
eral public in the safety of diagnostic ultrasound
examinations. Diagnostic ultrasound should not be per-
formed without upper intensity limits.
Rebuttal
Dr. O’Brien has clearly stated the problems perceived to
be associated with the existence of guideline upper limits for
diagnostic ultrasound. However, removing the present limitsMedical Physics, Vol. 28, No. 1, January 2001would not solve the problems he has listed because ~1!
manufacturers would still have to follow complicated proce-
dures in order to provide the output display indices for FDA
clearance; ~2! the present limits are justified, to some extent,
by extensive research and through considerations of bioef-
fects mechanisms; ~3! the elimination of limits would do
little to advance knowledge or education about safety issues;
~4! safety concerns related to present outputs would certainly
not be ameliorated by the removal of upper limits; ~5! in fact,
higher levels are not prohibited, and a truly compelling new
device requiring levels in excess of the guidelines can gain
FDA approval by demonstrating safety and efficacy; ~6!
greater advances in diagnostic ultrasound would be obtained
by improving training in imaging procedures, safety issues,
and diagnostic interpretation than by slight improvements in
images at higher intensities.
The removal of guideline limits would permit manufac-
turers to design diagnostic ultrasound instruments to engi-
neering limits regardless of safety issues, even though the
engineering objective may not serve more general medical
needs and desires. Physicians and sonographers should focus
on the art of sonography and diagnosis rather than on com-
plex safety issues related to the selection of an intensity for
each examination. Many patients do not receive any discern-
ible benefit from a diagnostic test, and consequently expect
to be protected from unnecessary levels of risk. The present
upper limit guidelines, though less than perfect, satisfy these
general needs and work well in the real world of incomplete
safety information and inadequate education. Manufacturers,
sonographers, and patients all benefit from the framework
provided by the existing approval process. Guideline upper
limits for diagnostic ultrasound should be continually im-
proved, but should not be removed.
1 FDA, ‘‘Information for manufacturers seeking clearance of diagnostic
ultrasound systems and transducers.’’ CDRH, U. S. Food and Drug Ad-
ministration, Rockville, MD, 1997.
2 NCRP, ‘‘Exposure criteria for medical diagnostic ultrasound: I. Criteria
based on thermal mechanisms.’’ National Council on Radiation Protec-
tion and Measurement, Bethesda, MD, 1992.
